tert-butyl 2-(3-acetyl-1H-indazol-1-yl)acetate → 2-(3-Acetyl-1H-indazol-1-yl)acetic acid
Reaction equation
[C:1]([C:4]1[C:12]2[C:7](=[CH:8][CH:9]=[CH:10][CH:11]=2)[N:6]([CH2:13][C:14]([O:16]C(C)(C)C)=[O:15])[N:5]=1)(=[O:3])[CH3:2].C(C1C2C(=CC=C(OC(F)(F)F)C=2)N(CC(O)=O)C=1)(=O)C>>[C:1]([C:4]1[C:12]2[C:7](=[CH:8][CH:9]=[CH:10][CH:11]=2)[N:6]([CH2:13][C:14]([OH:16])=[O:15])[N:5]=1)(=[O:3])[CH3:2]Participants
3
Procedure
The title compound was prepared from tert-butyl 2-(3-acetyl-1H-indazol-1-yl)acetate in a similar manner as described in step C of Scheme A13 for the preparation of (3-acetyl-5-trifluoromethoxy-indol-1-yl)-acetic acid. MS: 219 [M+H]+; tR (HPLC conditions k): 2.78 min.
Workup
- custom2.78 min.
Sources & evidence
- ORD record
- ord-4f2d0d8b79c846648317e94013c25ab0
- Source dataset
- uspto-grants-2015_07
- Patent number
- US09085555B2
Reaction notes
Loading…